Fundraising Fox

BioCryst Pharmaceuticals

NASDAQ: BCRX

1 known investors

Find your way into BioCryst Pharmaceuticals

BioCryst is a global biotechnology company focused on drug discovery, development, and commercialization of oral small-molecule and injectable protein therapeutics. It develops novel medicines for patients with hereditary angioedema (HAE) and other rare diseases.

Biotech

Founders & leadership

BG
Babar GhiasChief Financial Officer and Treasurer
AP
Alane P. BarnesinChief Legal Officer and Corporate Secretary
RS
Ronald S. DullingerChief Commercial Officer
SM
Sandeep M. MenonChief Research and Development Officer
CKCharles K. Gayer
Charles K. GayerinPresident and Chief Executive Officer

Investors · 1

Invivo Capital PartnersBarcelona · $2.2M – $4.3M

In the news

Squarepoint Ops LLC Buys 134,949 Shares of BioCryst Pharmaceuticals, Inc. $BCRXmarketbeat.com · Sep 2026WINTON GROUP Ltd Raises Stake in BioCryst Pharmaceuticals, Inc. $BCRXmarketbeat.com · Sep 2026NFJ Investment Group LLC Makes New $2.79 Million Investment in BioCryst Pharmaceuticals, Inc. $BCRXmarketbeat.com · Aug 2026

Frequently asked questions

What does BioCryst Pharmaceuticals do?
BioCryst is a global biotechnology company focused on drug discovery, development, and commercialization of oral small-molecule and injectable protein therapeutics. It develops novel medicines for patients with hereditary angioedema (HAE) and other rare diseases.
Who are BioCryst Pharmaceuticals's investors?
BioCryst Pharmaceuticals's investors include Invivo Capital Partners.